Telsey Advisory lowered the firm’s price target on On Holding (ONON) to $65 from $67 and keeps an Outperform rating on the shares. The firm continues to see the stock as a unique story with multiple avenues for global growth via owned stores, wholesale …
Acadia Pharmaceuticals ACAD reported first-quarter 2025 earnings of 11 cents per share, which beat the Zacks Consensus Estimate of 10 cents. In the year-ago quarter, the company had reported earnings of 10 cents per share. Acadia recorded total revenues of $244.3 million, which surpassed …
Murphy Oil Corporation MUR delivered first-quarter 2025 adjusted net earnings of 56 cents per share, which surpassed the Zacks Consensus Estimate of 48 cents by 16.7%. However, the bottom line decreased 34.1% from the year-ago quarter’s 85 cents. (See the Zacks Earnings Calendar to …
Key Points Paycom put up better first-quarter numbers than most investors were expecting, although revenue growth slowed to 6%, and gains in adjusted net income were limited to less than 8%. Founder/CEO Chad Richison commented on the automation-centered approach that Paycom is taking as …
Eli Lilly (LLY) shares take a dip after Politico reports that President Trump will sign a new executive order around drug prices. Among chip stocks, Arm Holdings (ARM) slips lower after it was announced the Trump administration plans to repeal Biden-era curbs on AI …
Arm Holdings (NASDAQ:ARM) shares fell more than 8% in premarket trading on Thursday after the chip designer issued a softer-than-expected fiscal 2026 first-quarter outlook. Morgan Stanley analyst Lee Simpson, who has an Overweight rating and a $150 price target, noted that while the company's …
Scotiabank analyst Patrick Colville raised the firm’s price target on Qualys (QLYS) to $142 from $140 and keeps a Sector Perform rating on the shares. The company delivered a “good enough” Q1, which was a positive after its close peer Tenable’s (TENB) “disappointment” last …
Needham lowered the firm’s price target on Sarepta (SRPT) to $125 from $183 and keeps a Buy rating on the shares. The company faced significant pressure following earnings, triggered by the appointment of Vinay Prasad to head CBER, as Dr. Prasad is a known …
Stifel lowered the firm’s price target on Lindblad Expeditions (LIND) to $17 from $18 and keeps a Buy rating on the shares. The firm notes that shares spiked following the company’s “impressive” Q1 earnings release, eventually settling for a more modest gain on the …
By John Vandermosten, CFANASDAQ:LNTHREAD THE FULL LNTH RESEARCH REPORT Lantheus Holdings, Inc. (NASDAQ:LNTH) reported first quarter 2025 financial and operational results on May 7th, producing sales of $373 million, a 1% increase over 1Q:24 levels. Pylarify, TechneLite, and Other Precision Diagnostics saw a year …